Copyright
©The Author(s) 2018.
World J Gastrointest Oncol. Nov 15, 2018; 10(11): 431-438
Published online Nov 15, 2018. doi: 10.4251/wjgo.v10.i11.431
Published online Nov 15, 2018. doi: 10.4251/wjgo.v10.i11.431
Figure 1 Overall survival data of patients who received hepatic arterial infusion chemotherapy treatment (n = 168).
The median survival time of left-sided colorectal cancer liver metastasis patients was 16.3 mo (curve A). The median survival time of right-sided colorectal cancer liver metastasis patients was 9.3 mo (curve B).
Figure 2 Progression-free survival data of patients who received hepatic arterial infusion chemotherapy treatment (n = 168).
The median PFS of left sided colorectal cancer liver metastasis patients was 5.7 mo (curve A). The median PFS of right sided colorectal cancer liver metastasis patients was 4.2 mo (curve B).
- Citation: Zhang HY, Guo JH, Gao S, Chen H, Wang XD, Zhang PJ, Liu P, Cao G, Xu HF, Zhu LZ, Yang RJ, Li J, Zhu X. Effect of primary tumor side on survival outcomes in metastatic colorectal cancer patients after hepatic arterial infusion chemotherapy. World J Gastrointest Oncol 2018; 10(11): 431-438
- URL: https://www.wjgnet.com/1948-5204/full/v10/i11/431.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v10.i11.431